Compounds > at 2153
Page last updated: 2024-09-03

at 2153 and 1,2-bis(3,5-dioxopiperazin-1-yl)ethane

at 2153 has been researched along with 1,2-bis(3,5-dioxopiperazin-1-yl)ethane in 1 studies

Compound Research Comparison

Studies
(at 2153)		Trials
(at 2153)		Recent Studies (post-2010)
(at 2153)		Studies
(1,2-bis(3,5-dioxopiperazin-1-yl)ethane)		Trials
(1,2-bis(3,5-dioxopiperazin-1-yl)ethane)		Recent Studies (post-2010) (1,2-bis(3,5-dioxopiperazin-1-yl)ethane)
13002202

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, DY; Lu, TR1

Reviews

1 review(s) available for at 2153 and 1,2-bis(3,5-dioxopiperazin-1-yl)ethane

ArticleYear
Antimetastatic activities and mechanisms of bisdioxopiperazine compounds.
    Anti-cancer agents in medicinal chemistry, 2010, Volume: 10, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Transformed; Fibrinogen; Humans; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Piperazines; Razoxane

2010